“…Since the introduction of this technology in its current form, positive results have been reported in psychiatry ( Blumberger et al, 2012 ; Demirtas-Tatlidede et al, 2013 ; Martin et al, 2011 ) and neurorehabilitation ( Hernandez-Pavon and Harvey, 2019 ; Lindenberg et al, 2012 ). tDCS has also been suggested as a promising therapy for patients with several chronic pain conditions, including fibromyalgia ( Villamar et al, 2013 ), pain due to traumatic spinal cord injury ( Fregni et al, 2006 ; Soler et al, 2010 ), chronic pelvic pain ( Divandari et al, 2019 ; Fenton et al, 2009 ), refractory orofacial pain ( Antal and Paulus, 2011 ), postherpetic neuralgia ( DosSantos et al, 2012 ), painful diabetic polyneuropathy ( Kim et al, 2013 ), chronic neuropathic pain following a burn injury ( Portilla et al, 2013 ), trigeminal neuralgia ( Hagenacker et al, 2014 ), lower back pain ( Schabrun et al, 2014 ), and migraines ( Antal et al, 2011 ; de Brito Aranha et al, 2022 ; Viganò et al, 2013 ). The modulatory effects of tDCS are reversible and painless, and its portability represents the possibility of home-based pain treatment ( Nitsche et al, 2008 ; Pacheco-Barrios et al, 2020 ).…”